🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving Stroke Care in North-Norway Through Artificial Intelligence

RecruitingNAAges 18 Years - anyAllUniversity Hospital of North Norway
NCT05903898 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective observational multi-center intervention study. The study aims to evaluate whether an artificial intelligence (AI) support tool for radiological image processing (StrokeSens, Circle NVI) can accelerate decision making and increase detection rate in patients with an acute ischemic stroke caused by intracranial large vessel occlusion (LVO) or medium vessel occlusion (MeVO) in Northern Norway. Relevant outcomes will be compared between centres with and without available software during the study period.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with acute stroke symptoms admitted to a participating hospital within 24 hours of symptom onset Exclusion Criteria: * Patients not available for follow-up assessments (e.g. non-resident)
💊

What it tests

  • AI software StrokeSens (Circle NVI)
📍

Where

1 site
University Hospital of North Norway
Tromsø, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy